Plasma phospho-tau181 increases with Alzheimer's disease clinical severity and is associated with tau- and amyloid-positron emission tomography

Clinical Severity ◽

Emission Tomography ◽

A 4-Year Follow-Up of Subjects with Visually Equivocal Amyloid Positron Emission Tomography Findings from the Alzheimer’s Disease Neuroimaging Initiative Cohort

Nuclear Medicine and Molecular Imaging ◽

10.1007/s13139-021-00690-x ◽

2021 ◽

Author(s):

Minyoung Oh ◽

◽

Minjung Seo ◽

Sun Young Oh ◽

Heeyoung Kim ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Emission Tomography ◽

P2-578: COST-EFFECTIVENESS OF USING AMYLOID POSITRON EMISSION TOMOGRAPHY FOR ASSESSING PRODROMAL ALZHEIMER'S DISEASE IN INDIVIDUALS WITH MILD COGNITIVE IMPAIRMENT

Alzheimer s & Dementia ◽

10.1016/j.jalz.2019.06.2987 ◽

2019 ◽

Vol 15 ◽

pp. P844-P844

Author(s):

HyunChul Youn ◽

Young-Sil Lee ◽

Jeon-Ho Lee ◽

Ji Won Han ◽

Joon Hyuk Park ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Cognitive Impairment ◽

Mild Cognitive Impairment ◽

Cost Effectiveness ◽

Emission Tomography ◽

Positron Emission ◽

Prodromal Alzheimer’S Disease

[18 F]flutemetamol amyloid positron emission tomography in preclinical and symptomatic Alzheimer's disease: Specific detection of advanced phases of amyloid-β pathology

Alzheimer s & Dementia ◽

10.1016/j.jalz.2015.05.018 ◽

2015 ◽

Vol 11 (8) ◽

pp. 975-985 ◽

Cited By ~ 75

Author(s):

Dietmar Rudolf Thal ◽

Thomas G. Beach ◽

Michelle Zanette ◽

Kerstin Heurling ◽

Aruna Chakrabarty ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Amyloid Β ◽

Emission Tomography ◽

Specific Detection ◽

Positron Emission ◽

Disease Specific

Amyloid Positron Emission Tomography Imaging for the Differential Diagnosis of Alzheimer's Disease

Journal of Nippon Medical School ◽

10.1272/jnms.81.2 ◽

2014 ◽

Vol 81 (1) ◽

pp. 2-3

Author(s):

Amane Tateno ◽

Takeshi Sakayori ◽

Yoshiro Okubo

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Differential Diagnosis ◽

Positron Emission Tomography Imaging ◽

Emission Tomography ◽

Tomography Imaging ◽

Amyloid positron emission tomography (PET) imaging in the timely diagnosis of Alzheimer's disease

http://isrctn.com/ ◽

10.1186/isrctn17685148 ◽

2015 ◽

Author(s):

Naji Tabet

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Pet Imaging ◽

Emission Tomography ◽

Timely Diagnosis ◽

Correction to: Different aspects of Alzheimer’s disease-related amyloid β-peptide pathology and their relationship to amyloid positron emission tomography imaging and dementia

Acta Neuropathologica Communications ◽

10.1186/s40478-020-01005-5 ◽

2020 ◽

Vol 8 (1) ◽

Author(s):

Dietmar Rudolf Thal ◽

Alicja Ronisz ◽

Thomas Tousseyn ◽

Ajeet Rijal Upadhaya ◽

Karthikeyan Balakrishnan ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Amyloid Β ◽

Positron Emission Tomography Imaging ◽

Emission Tomography ◽

Amyloid Β Peptide ◽

Tomography Imaging ◽

Voxel-Based Analysis of Amyloid Positron Emission Tomography Probe [11C]BF-227 Uptake in Mild Cognitive Impairment and Alzheimer’s Disease

Dementia and Geriatric Cognitive Disorders ◽

10.1159/000318754 ◽

2010 ◽

Vol 30 (2) ◽

pp. 101-111 ◽

Cited By ~ 10

Author(s):

He Shao ◽

Nobuyuki Okamura ◽

Kentaro Sugi ◽

Shozo Furumoto ◽

Katsutoshi Furukawa ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Cognitive Impairment ◽

Mild Cognitive Impairment ◽

Emission Tomography ◽

Cognitive reserve hypothesis: Pittsburgh Compound B and fluorodeoxyglucose positron emission tomography in relation to education in mild Alzheimer's disease

Yearbook of Neurology and Neurosurgery ◽

10.1016/s0513-5117(08)79054-9 ◽

2008 ◽

Vol 2008 ◽

pp. 7-8

Author(s):

T.J. Grabowski

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Fluorodeoxyglucose Positron Emission

Cognitive Reserve ◽

Emission Tomography ◽

Fluorodeoxyglucose Positron Emission Tomography ◽

Pittsburgh Compound B ◽

Positron Emission ◽

Tau Positron Emission Tomography (PET) Longitudinal Substudy Associated With: Study of Crenezumab Versus Placebo in Preclinical Presenilin1 (PSEN1) E280A Mutation Carriers in the Treatment of Autosomal-Dominant Alzheimer's Disease

Case Medical Research ◽

10.31525/ct1-nct03977584 ◽

2019 ◽

Author(s):

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Autosomal Dominant Alzheimer’S Disease

Autosomal Dominant ◽

Emission Tomography ◽

Mutation Carriers ◽

Positron Emission ◽

Significant effects of cholinesterase inhibitors on tau pathology in the Alzheimer's disease continuum: An in vivo positron emission tomography study

International Journal of Geriatric Psychiatry ◽

10.1002/gps.5522 ◽

2021 ◽

Author(s):

Fumihiko Yasuno ◽

Hiroyuki Minami

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Cholinesterase Inhibitors ◽

Emission Tomography ◽

Positron Emission Tomography Study ◽

Tau Pathology ◽